by Steven A. Grossman | Jul 19, 2025 | Uncategorized
Dear FDA Matters subscribers–—Second edition of Q&A Friday, a new feature for subscribers. Each “Q&A Friday” will go to subscribers first, then posted on the website a week later. It is on the record, so subscribers (including reporters) can use and circulate...
by Steven A. Grossman | Jul 18, 2025 | Short Takes and Updates
A little under half of the FDA’s roughly $7 billion budget is funded by user fees. Tobacco user fees pay for the entire tobacco program, while medical product user fees pay for between 20% and 70% of most medical programs.Food programs are, effectively, “all taxpayer...
by Steven A. Grossman | Jul 8, 2025 | Short Takes and Updates
“The One Big Beautiful Bill Act” (aka OBBBA) was signed into law on July 4, 2025. The immediate and long-term consequences of this bill are the most important story to write about today. Other topics can wait. ———————Whether...
by Steven A. Grossman | Jul 4, 2025 | Uncategorized
Dear FDA Matters subscribers–Introducing Q&A Friday, a new feature for subscribers.Each Friday’s Q&A will go to subscribers first, then it will be posted on the website about a week later. Like all FDA Matters analysis (including everything on the website) it...
by Steven A. Grossman | Jun 30, 2025 | Short Takes and Updates
There is very little support among stakeholders and FDA employees for the 2025 version of the FDA.[1] Some of us are discouraged. Some of us are trying hard to find the good in agency proposals and actions. Regardless of where any of us stand, all of us need to be...
